Delivery Order SPE2DX22D0010-SPE2D826FBU41
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 10, 2025, for the supply of Adderall 30mg tablets (100-count packages) under a firm fixed-price contract valued at $1,225.66. The contract, which is a non-set-aside competitive award, calls for ultimate completion by November 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 10 mg tablets (100-count) on October 27, 2025, with a ceiling value of $2,451.32 and an ultimate completion date of October 28, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The place of performance is listed as Conshohocken, Pennsylvania, where...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $4,061.26 delivery order to AmerisourceBergen Drug Corp for Adderall tablets 20mg, with a completion date of December 3, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $1,225.66 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Adderall 10 mg tablets in quantities of 100. This firm fixed-price contract, with an ultimate completion date of December 4, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The contract was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Adderall 5 mg tablets in quantities of 100 units. This competitively awarded, non-set-aside contract has a firm fixed price ceiling value of $1,266.02 and is scheduled for completion by May 7, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Adderall 20 mg tablets in quantities of 100, with a ceiling value of $4,902.64. This firm fixed-price delivery order, with an ultimate completion date of December 12, 2025, represents a non-set-aside competitive award to support federal medical procurement needs. The contract is performed from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $12,063.51 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Adderall 10 mg tablets (100-count units), with an ultimate completion date of December 8, 2025. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,325.97 for 100 tablets of Adderall 30mg on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,160.91 for 100 tablets of Adderall 15 mg on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Adderall 5 mg tablets in quantities of 100 units. This firm fixed-price delivery order, valued at $3,219.30, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The award was made without a set-aside designation through open...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FBU41Delivery Order
The U.S. Department of Defense, through its Medical Supply Chain division, awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Adderall tablets, 20 milligram strength, with a ceiling value of $2,033.59. This non-set-aside, competitively awarded contract employs firm fixed pricing and is scheduled for completion by December 17, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this order as part of its comprehensive pharmaceutical supply operations supporting military and defense healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver diverse pharmaceutical products across multiple therapeutic domains through open competition. This delivery order for Adderall tablets supports the Defense Department's medical supply requirements and reflects AmerisourceBergen's ongoing role as a primary pharmaceutical vendor for DoD healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 12/15/25 |